We are live on ! Find out more
TOBAM

TOBAM Portfolio holdings

AUM $244M Turnover 23.99%
1-Year Est. Return 22.99%
This Fund
S&P 500
This Quarter Est. Return
+5.67%
1 Year Est. Return
+22.99%
3 Year Est. Return
+76.51%
5 Year Est. Return
+69.97%
10 Year Est. Return
+288.16%
AUM
$3.02B
AUM Growth
-$517M
Cap. Flow
-$664M
Cap. Flow %
-22%
Top 10 Hldgs %
32.13%
Holding
158
New
26
Increased
40
Reduced
69
Closed
23
Avg Time Held
0.7 years
Top 10 Avg Time Held
0.4 years
Top 20 Avg Time Held
0.6 years

Top Buys

Rank Stock Value
1
CLX icon
Clorox
CLX
+$75.6M
2
SLXP
Salix Pharmaceuticals
SLXP
+$53M
3
KO icon
Coca-Cola
KO
+$51.7M
4
GNW icon
Genworth Financial
GNW
+$49.3M
5
VER
VEREIT
VER
+$43.4M

Top Sells

Rank Stock Value
1
DGX icon
Quest Diagnostics
DGX
+$109M
2
HPQ icon
HP
HPQ
+$82.4M
3
ESRX
Express Scripts Holding
ESRX
+$68.2M
4
ISRG icon
Intuitive Surgical
ISRG
+$58.9M
5
EXC icon
Exelon
EXC
+$55.9M

Sector Composition

Rank Sector Weight
1 Real Estate 15.55%
2 Consumer Staples 14.94%
3 Utilities 12.81%
4 Technology 12.56%
5 Consumer Discretionary 9.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
AGNC icon
1
AGNC Investment
AGNC
$10B
$134M 4.44%
6,134,614
+188,409
+3% +$4.25M
2013 Q2
6 quarters
NLY icon
2
Annaly Capital Management
NLY
$13.4B
$133M 4.41%
3,080,080
-86,168
-3% -$3.9M
2013 Q2
6 quarters
FE icon
3
FirstEnergy
FE
$27.3B
$111M 3.68%
2,846,429
-952,347
-25% -$34.9M
2013 Q4
4 quarters
EXC icon
4
Exelon
EXC
$47B
$98M 3.24%
3,703,590
-2,178,721
-37% -$55.9M
2013 Q2
6 quarters
CLX icon
5
Clorox
CLX
$12.7B
$97.9M 3.24%
939,798
+755,798
+411% +$75.6M
2014 Q3
1 quarter
JNPR icon
6
DELISTED
Juniper Networks
JNPR
$89.4M 2.96%
4,005,693
-169,065
-4% -$3.59M
2013 Q2
6 quarters
WFM
7
DELISTED
Whole Foods Market
WFM
$78.9M 2.61%
1,565,318
+323,333
+26% +$14.2M
2014 Q2
2 quarters
EW icon
8
Edwards Lifesciences
EW
$59.7B
$78.2M 2.59%
3,684,768
-1,474,104
-29% -$29.6M
2013 Q2
6 quarters
ULTA icon
9
Ulta Beauty
ULTA
$26.9B
$75M 2.49%
587,038
-50,917
-8% -$6.24M
2013 Q2
6 quarters
PETM
10
DELISTED
PetSmart
PETM
$74.5M 2.47%
916,345
-156,992
-15% -$11.6M
2014 Q3
1 quarter
RYN icon
11
Rayonier
RYN
$6.03B
$73M 2.42%
2,880,409
+890,839
+45% +$23.9M
2014 Q2
2 quarters
GEN icon
12
Gen Digital
GEN
$17.9B
$70.9M 2.35%
2,763,681
-1,734,979
-39% -$43.1M
2014 Q1
3 quarters
PCG icon
13
PG&E
PCG
$30.7B
$70.1M 2.32%
1,317,345
-21,270
-2% -$1.05M
2014 Q2
2 quarters
DG icon
14
Dollar General
DG
$29.5B
$68.7M 2.28%
971,973
-382,825
-28% -$24.9M
2013 Q2
6 quarters
CLB icon
15
Core Laboratories
CLB
$385M
$67.3M 2.23%
559,196
-4,595
-0.8% -$604K
2014 Q2
2 quarters
FTR
16
DELISTED
Frontier Communications
FTR
$65.3M 2.16%
652,410
+70,246
+12% +$6.89M
2014 Q2
2 quarters
SPLS icon
17
DELISTED
Staples
SPLS
$59M 1.95%
3,257,388
+2,916,985
+857% +$40.7M
2014 Q2
2 quarters
TSN icon
18
Tyson Foods
TSN
$22B
$54.9M 1.82%
1,370,399
-774,515
-36% -$31.4M
2014 Q1
3 quarters
AAPL icon
19
Apple
AAPL
$5.07T
$52.9M 1.75%
1,915,308
-1,813,040
-49% -$49.3M
2013 Q2
6 quarters
SWN icon
20
DELISTED
Southwestern Energy
SWN
$52.6M 1.74%
1,926,169
-53,535
-3% -$1.72M
2014 Q2
2 quarters
VER
21
DELISTED
VEREIT
VER
$52M 1.72%
1,150,224
+885,914
+335% +$43.4M
2014 Q2
2 quarters
RAX
22
DELISTED
Rackspace Hosting
RAX
$51.3M 1.7%
1,095,121
+42,483
+4% +$1.75M
2013 Q2
6 quarters
KO icon
23
Coca-Cola
KO
$413B
$51.1M 1.69%
+1,209,906
New +$51.7M
2014 Q4
0 quarters
SLXP
24
DELISTED
Salix Pharmaceuticals
SLXP
$50.3M 1.67%
+437,377
New +$53M
2014 Q4
0 quarters
VRTX icon
25
Vertex Pharmaceuticals
VRTX
$132B
$45.7M 1.51%
384,827
-130,648
-25% -$14.7M
2013 Q2
6 quarters

Similar funds

TOBAM's Q4 2014 Portfolio in Review

As of Q4 2014, TOBAM held 158 positions worth $3.02B, down 15% from $3.54B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

TOBAM withdrew a net $664M in Q4 2014, closing 23 positions and reducing 69 holdings. Its most notable exit was Endo International, an estimated $49.1M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 16% of assets, up from 12% a quarter earlier, followed by Consumer Staples and Utilities.

Against the trend, TOBAM opened a new position in Salix Pharmaceuticals worth $50.3M.

  • TOBAM's largest Q4 2014 buy was Salix Pharmaceuticals: 437,377 shares worth $50.3M.
  • TOBAM added most to Clorox in Q4 2014, an estimated $75.6M increase.
  • TOBAM's biggest Q4 2014 reduction was Quest Diagnostics, cutting an estimated $109M.
  • TOBAM fully exited Endo International in Q4 2014, selling an estimated $49.1M.
  • TOBAM's ten largest holdings make up 32% of its $3.02B portfolio in Q4 2014.
  • TOBAM opened 26 new positions and closed 23 in Q4 2014.
  • TOBAM's portfolio value fell 15% quarter-over-quarter to $3.02B.

Based on TOBAM's 13F filing for Q4 2014, filed 20 Feb 2015.